| Product Information |
DR-XY47366_PI_01.pdf
|
| Registration Number |
DR-XY47366
|
| Generic Name |
Fluticasone furoate + Umeclidinium (as bromide) +
Vilanterol (as trifenatate)
|
| Brand Name |
Trelegy Ellipta
|
| Dosage Strength |
100 mcg/62.5 mcg/25 mcg
|
| Dosage Form |
Dry Powder For Inhalation
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
Alu blister strip fitted in a plastic device inhaler enclosed in sealed foil laminate tray with desiccant packet x 30 actuation doses (Box of l's) and 14 actuation doses (Box of l's) [as Physician's Sample)
|
| Manufacturer |
Glaxo Operations UK Ltd.
|
| Country of Origin |
United Kingdom
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
GlaxoSmithKline Philippines, Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
08 September 2021
|
| Expiry Date |
08 September 2024
|